Detalhe da pesquisa
1.
Inhibitors of energy metabolism interfere with antibiotic-induced death in mycobacteria.
J Biol Chem
; 294(6): 1936-1943, 2019 02 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30530783
2.
Exploiting the synthetic lethality between terminal respiratory oxidases to kill Mycobacterium tuberculosis and clear host infection.
Proc Natl Acad Sci U S A
; 114(28): 7426-7431, 2017 07 11.
Artigo
Inglês
| MEDLINE | ID: mdl-28652330
3.
An amiloride derivative is active against the F1Fo-ATP synthase and cytochrome bd oxidase of Mycobacterium tuberculosis.
Commun Biol
; 5(1): 166, 2022 02 24.
Artigo
Inglês
| MEDLINE | ID: mdl-35210534
4.
Dual inhibition of the terminal oxidases eradicates antibiotic-tolerant Mycobacterium tuberculosis.
EMBO Mol Med
; 13(1): e13207, 2021 01 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33283973
5.
Bioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosis.
Front Cell Infect Microbiol
; 10: 611683, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33505923
6.
Derailing the aspartate pathway of Mycobacterium tuberculosis to eradicate persistent infection.
Nat Commun
; 10(1): 4215, 2019 09 16.
Artigo
Inglês
| MEDLINE | ID: mdl-31527595